Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value

ASSERTIO THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value

ASSERTIO THERAPEUTICS, INC. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $14.82 million as of 2016-12-31, per its 10-K filed 2017-02-24.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2017-02-24

  • 2016-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $14.82M.
  • 2015-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $14.97M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
2016-12-31$14.82M
10-K · filed 2017-02-24
2015-12-31$14.97M
10-K · filed 2017-02-24